We have demonstrated altered expression of the ionotropic glutamate NMDARs in postmortem samples from patients with RTT and Mecp2-null mice [28,29], while others show increased levels of glutamate in patients with RTT [109] and the RTT mouse model [31]. This evidence concerns the gene MECP2 and Rett syndrome.